The Failing Liver: Treating Its Complications, and Dosing Drugs Around It
The liver is the body's chemical factory — and when it fails, the problems ripple everywhere. Two clever treatments manage its worst complications, and a whole set of prescribing rules changes because the failing liver can no longer handle drugs normally. This is where the pharmacokinetics chapter comes back with real, life-or-death consequences.
The liver does an astonishing number of jobs: it metabolises drugs and toxins, makes clotting factors and proteins, processes nutrients, and clears waste products from the blood. When chronic liver disease scars the liver (cirrhosis), all these functions falter, and the consequences spread through the whole body. Three of the classic complications need specific management — a confused brain, fluid in the abdomen, and dangerous bleeding — and, just as importantly, the failing liver changes how we must prescribe almost every other drug. This article ties the gut section to the pharmacokinetics chapter in the most clinically vivid way.
Two treatable complications
Lactulose for the confused brain; diuretics for the fluid. The first complication is hepatic encephalopathy — a confused, drowsy, and eventually comatose brain. It happens because the failing liver can no longer clear toxins (especially ammonia, made by gut bacteria) from the blood, and these build up and poison the brain. The clever treatment is lactulose — the osmotic laxative from the constipation article, used here for a completely different purpose. Lactulose works in the gut to trap ammonia and speed its removal in the stool, lowering the blood ammonia and clearing the confusion. (An antibiotic, rifaximin, that stays in the gut and reduces the ammonia-producing bacteria, is often added.) The second complication is ascites — fluid accumulating in the abdomen, driven by the liver disease and salt-and-water retention. It's managed with salt restriction and diuretics — and here's a nice specific link: the preferred diuretic is spironolactone (the potassium-sparing aldosterone blocker from the cardiovascular chapter), because ascites is driven partly by high aldosterone. So two everyday complications of liver failure are treated by drugs you already know, borrowed for new roles — lactulose from GI, spironolactone from cardiology.
Prescribing around a failing liver
The second half of this topic is arguably more important day to day: how liver failure changes prescribing for every other drug — a direct, high-stakes application of the pharmacokinetics chapter. Because the liver metabolises most drugs, a failing liver clears them more slowly, so many drugs accumulate and their doses must be reduced or the drugs avoided. Several specific dangers stand out. Sedatives and opioids are especially risky — a diseased liver clears them poorly, so normal doses can build up and, worse, they can tip a vulnerable brain into hepatic encephalopathy, so they're used with great caution or avoided. Because the liver makes clotting factors, liver disease impairs clotting, which interacts with anticoagulants and bleeding risk. And a crucial toxin warning: paracetamol overdose is a leading cause of acute liver failure (its toxic metabolite overwhelms the liver's defences) — a reminder that the very organ that processes drugs can be destroyed by one. There's a matching antidote worth knowing: N-acetylcysteine, given for paracetamol overdose, replenishes the liver's protective glutathione and can prevent the damage if given in time. The overarching lesson is that in liver disease you must think twice about every prescription: is this drug metabolised by the liver? Will it accumulate? Could it worsen encephalopathy or bleeding? The failing liver turns routine prescribing into a careful, kinetics-aware exercise.
- Hepatic encephalopathy (toxins/ammonia poisoning the brain) → treat with lactulose (± rifaximin).
- Ascites (fluid in abdomen) → salt restriction + diuretics; preferred diuretic is spironolactone.
- The failing liver clears drugs slowly → many accumulate; reduce doses or avoid.
- Sedatives/opioids are risky (accumulate + can precipitate encephalopathy); liver disease impairs clotting.
- Paracetamol overdose causes acute liver failure — antidote is N-acetylcysteine (given in time).
Liver disease is where the pharmacokinetics chapter stops being theory and becomes a matter of survival. The core idea from that chapter — that the liver metabolises most drugs — has a stark consequence when the liver fails: drugs it would normally clear now pile up to toxic levels at ordinary doses. That's why a standard dose of a sedative can be an overdose in a cirrhotic patient, and why it can push them into a coma of encephalopathy. Every drug you consider in liver disease should trigger the question 'how does the liver handle this, and what happens if it can't?' The elegant flip side is the treatments: lactulose and spironolactone, both borrowed from other chapters, quietly manage the liver's worst complications. Understand the failing liver as both a broken drug-processing organ and a source of specific complications, and its pharmacology becomes coherent rather than intimidating.
- Giving normal doses of liver-metabolised drugs in liver failure — they accumulate to toxic levels.
- Using sedatives/opioids freely in liver disease — can precipitate hepatic encephalopathy.
- Forgetting lactulose treats encephalopathy (not just constipation) by clearing ammonia.
- Missing that paracetamol overdose destroys the liver — give N-acetylcysteine promptly.
What is the main treatment for hepatic encephalopathy?
- Hepatic encephalopathy → lactulose (± rifaximin) to clear ammonia; ascites → salt restriction + spironolactone.
- The failing liver clears drugs slowly — reduce doses or avoid; sedatives/opioids especially risky.
- Liver disease impairs clotting; paracetamol overdose causes acute liver failure.
- N-acetylcysteine is the antidote for paracetamol overdose — give in time.
- Katzung BG. Basic & Clinical Pharmacology — Drugs & the liver; hepatic disease.
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Pharmacotherapy of liver disease.
- AASLD / EASL — Guidelines on hepatic encephalopathy & ascites.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — The liver & drug handling.
